ABSTRACT-Our objective was to determine how circulatory failure develops following systemic administration of potassium cyanide (KCN). We used a noninhaled modality of intoxication, wherein the change in breathing pattern would not influence the diffusion of CN into the blood, akin to the effects of ingesting toxic levels of CN. In a group of 300 to 400 g rats, CN-induced coma (CN i.p., 7 mg/kg) produced a central apnea within 2 to 3 min along with a potent and prolonged gasping pattern leading to autoresuscitation in 38% of the animals. Motor deficits and neuronal necrosis were nevertheless observed in the surviving animals. To clarify the mechanisms leading to potential autoresuscitation versus asystole, 12 urethane-anesthetized rats were then exposed to the lowest possible levels of CN exposure that would lead to breathing depression within 7 to 8 min; this dose averaged 0.375 mg/kg/min i.v. At this level of intoxication, a cardiac depression developed several minutes only after the onset of the apnea, leading to cardiac asystole as PaO 2 reached value approximately 15 Torr, unless breathing was maintained by mechanical ventilation or through spontaneous gasping. Higher levels of KCN exposure in 10 animals provoked a primary cardiac depression, which led to a rapid cardiac arrest by pulseless electrical activity (PEA) despite the maintenance of PaO 2 by mechanical ventilation. These effects were totally unrelated to the potassium contained in KCN. It is concluded that circulatory failure can develop as a direct consequence of CN-induced apnea but in a narrow range of exposure. In this ''low'' range, maintaining pulmonary gas exchange after exposure, through mechanical ventilation (or spontaneous gasping), can reverse cardiac depression and restore spontaneous breathing. At higher level of intoxication, cardiac depression is to be treated as a specific and spontaneously irreversible consequence of CN exposure, leading to a PEA.
INTRODUCTION
Cyanide (CN) certainly represents the archetype of poison as it can kill, in very small amounts, within seconds or minutes. The mechanism of the rapid fatal outcome produced by CN is not always clear and even if the ultimate outcome is a profound cardiogenic shock leading to asystole, its mechanism of production remains equivocal. Indeed, CN can produce central apnea, due to an inhibition of the activity of medullary neurons (1, 2) , which rapidly opposes the initial hyperpnea produced by CN, eventually leading to hypoxemia-induced asystole; on the contrary, an acute primary depression in cardiac contractility leading to a pulseless electrical activity (PEA) is a welldescribed complication of acute CN poisoning (3) (4) (5) (6) (7) . In contrast to the research done on the development on specific CN antidotes, aimed at decreasing the concentration of CN in the blood and tissues by either trapping CN or speeding up its elimination as thiocyanide, the symptomatic treatments of the respiratory and circulatory depression produced by CN are currently lacking a well-accepted rational framework and standard of care.
Our specific objective was to determine the temporal profile of CN-induced apnea and CN-induced circulatory failure to identify the interactions between the depression in breathing and in cardiac function in keeping with the severity of the intoxication; the immediate outcome of a reduction in cardiac contractility resulting from CN-induced apnea versus a primary cardiac failure produced by CN (8, 9) . We used a systemic administration of CN, wherein CN rapidly diffuses to the blood stream, irrespective of the level of pulmonary ventilation as during CN ingestion (10, 11) . These intoxications differ from those produced by the inhalation of CN as during CN diffusion into the blood does not increase during the period of hyperventilation or decrease during the period apnea, produced by CN. We first focused our attention on the response of unsedated rats receiving a unique lethal dose of intraperitoneal (i.p.) CN salt (12) (13) (14) (15) , and then attempted to dissect the mechanisms leading to death or autoresuscitation that we saw in the ''i.p. model'' by using intravenous infusion of different, but well controlled, concentrations of potassium cyanide (KCN) (16) (17) (18) (19) that would all potentially lead to cardiac asystole.
CN-induced apnea in unanesthetized rats
Animal preparation and protocol (n ¼ 10)-Rats (336 AE 43 g) received an injection of CN i.p. at a dose of 7 mg/kg was reported to be lethal in approximately 75% of animals (12, 20) and also found to be lethal within less than 20 min. KCN was diluted in sterile saline at a concentration of 6 mg/mL. Clinical examinations were performed before then every minute for 30 min following CN administration. This examination included the determination of presence of the righting reflex, the response to hand clapping and air puff, the grasping reflex, and the withdrawal reflex. Breathing pattern and the presence of a cardiac pulse were monitored. Three animals were placed in a plethysmographic chamber for recording of the breathing pattern, as soon as they presented an apnea. Coma was defined by the disappearance of response to clapping and air puff along with the loss of the righting reflex. Animals that displayed a phase of somnolence, although all the reflexes were still preserved, were therefore not considered to present a coma. Breathing movements were monitored to identify tachypnea (rapid shallow breathing with a breathing frequency above 400/min), hypopnea (breathing frequency below 100/min), and production of abrupt and large breaths at a low frequency (gasping). During the first 48 h following KCN injection, each surviving animal was observed carefully for signs of distress or discomfort. Animals showing signs of prostration, inability to walk, eat, or drink, paralysis or obvious visual deficit were euthanized. The rats were anesthetized with 3.5% isoflurane in O 2 followed by urethane (1.2 g/kg, i.p.). The animals were then perfused transcardially with phosphate buffered saline followed by 10% neutral buffered formalin (NBF). The head of the animal was skinned, decapitated, and immersion fixed for 24 h in 10% NBF before brain removal. The brains were fixed for an additional 5 days before trimming into nine 5-mm coronal slices using a brain-trimming matrix (Zivic). Tissues were processed in an automated Tissue-Tek VIP processor and paraffin-embedded with a Tissue-Tek TEC embedding station (Sakura Finetek USA, Torrance, Calif). Sections were cut at 6 mm for routine hematoxylin & eosin staining. All tissues were examined by an American College of Veterinarian Pathologists pathologist blinded to treatment. All images were obtained with an Olympus BX51 microscope and DP71 digital camera using cellSens Standard 1.6 imaging software (Olympus America, Center Valley, Pa).
CN-induced apnea in urethane anesthetized animals
Animal preparation (n ¼ 22)-Rats weighing 448 AE 55 g were anesthetized with inhalation of isoflurane 3.5% in O 2 , followed by i.p. injection of urethane (1.2 g/kg). They were tracheostomized (14G Surflo catheter). A catheter (PE-50 tubing) was inserted into the right femoral artery for continuous monitoring of systemic arterial blood pressure and arterial blood sampling. A similar catheter was inserted into the left ventricle through the right carotid artery for continuous monitoring of left ventricular pressure. Additional catheters were inserted into the right femoral vein for KCN infusion and in the right jugular vein for drug administration.
The tracheal catheter was connected to a low dead space two-way valve (Hans Rudolph, Shawnee, Kans), and the inspiratory flow was measured using a pneumotachograph (1100 Series; Hans Rudolph) (21, 22) . The expiratory valve was connected to a series of two 5 mL mixing chambers. An additional source of air was introduced into the first mixing chamber in which flow was continuously measured using another pneumotachograph (1100 Series; Hans Rudolph). Mixed-diluted expired O 2 (FEO 2 ) and CO 2 fractions (FECO 2 ) were measured continuously using O 2 (Oxystar-100; CWE, Inc, Ardmore, Pa) and CO 2 (Model 17630; VacuMed, Ventura, Calif) analyzers, as previously described (23, 24) .
The arterial and ventricular catheters were connected to pressure transducers (BD DTXPlus Transducer; Becton Dickinson, Franklin Lakes, NJ; amplifier TA-100, CWE, Inc) to monitor arterial blood pressure and left ventricular pressure. Aortic blood flow and femoral blood flow were measured using transonic flow probes (Transonic Systems, Inc, Ithaca, NY) connected to the transit-time flowmeter (TS420; Transonic Systems Inc). Electrocardiogram was recorded by a bioelectric amplifier (differential AC amplifier, Model 1700; A-M Systems, Sequim, Wash).
All signals were digitized at 400 Hz using an analog-to-digital data acquisition system (Power Lab 16/35; ADInstruments, Inc, Colorado Springs, Colo) and were visualized online. All data were stored for further analysis by LabChart 7 (ADInstruments, Inc).
Breathing frequency (f) and tidal volume (V T ) were determined using peak detection and integration of the inspiratory flow signal, respectively, and minute ventilation (VE) was computed as f Â V T in body temperature and pressure saturated conditions. Oxygen uptake (VO2) was computed as previously described (23, 25) . Left ventricular systolic pressure (LVSP) and heart rate (HR) were determined and dP/dt computed as the derivative of the left ventricular pressure signal. Data were averaged over 10 s every 10 s.
Arterial blood gases, concentrations of lactate, and potassium were determined using i-stat analyzer (Abaxis, Union City, Calif).
Experimental protocol: intravenous KCN infusion-CN solutions were prepared using KCN (Sigma, St. Louis, Mo). KCN was diluted in sterile saline at a concentration of 0.5 mg/mL corresponding to a concentration of 7.7 mM of KCN.
The rational of the protocol used in this study was based on series of exploratory experiments: CN was infused at various higher rates (between 0.1 and 1.2 mg/min) in three rats (10 tests), not included in the current study. In keeping with these preliminary results, two levels of exposure were chosen: After 30 min of stable recording, KCN was infused at the rate of approximately 0.15 mg/min (0.37 mg/kg/min) in 12 rats. This rate produces a level of exposure that led to apnea within a few minutes according to our preliminary results and studies from Brierley et al. (18) . CN infusion was interrupted upon the cessation of the respiratory movements. The time to cardiac arrest was computed. PEA was defined as the persistent electrocardiogram signal (sinus rhythm) but with no effective cardiac contractions. The latter was defined as the moment when left ventricular pulse pressure reached a value of less than 10 mmHg for more than 10 s. Out of these 12 rats, the natural history of the apnea was studied without any intervention or with mechanical ventilation initiated 90 to 120 s following the last spontaneous breathing cycle. Arterial blood gases were determined before starting KCN infusion then approximately 100 s into apnea.
In a separate series of 10 rats, we studied the effects of infusing KCN at the rate of 0.3 mg/min (0.75 mg/kg/min, i.e., twice the rate producing an apnea), which would produce a very rapid drop in blood pressure sometimes even before apnea occurred. Infusion was performed while the animals were mechanically ventilated because they would all present an almost immediate apnea. Arterial blood gases, lactate, and potassium concentrations were determined before starting KCN infusion then 3, 5, and 7 min into the infusion periods.
Intravenous infusion of potassium chloride-A solution of potassium chloride (KCl) was prepared at the same molar concentration than ''high dose'' KCN protocol (7.7 mM). This solution was infused in a group of five rats at the same rate as KCN (0.6 mL/min) for 7 to 8 min. Arterial blood gases, lactate, and potassium concentrations were determined before starting KCl infusion then 7 min into the infusion period.
Statistical analysis
All results are presented as mean AE SD. All variables of interest (breathing pattern, blood pressure, dP/dt, ventricular pressure, cardiac output) were averaged every 10 s for comparison and analyzed over time using repeatedmeasured ANOVA followed by Bonferroni's post hoc comparisons. The changes from baseline level to the moment of apnea were compared using paired t test. All variables of interest were also compared between the KCl and KCN-intoxicated animals using an unpaired t test. The statistical analyses were conducted using GraphPad Prism 5 (Graphpad Software, La Jolla, Calif). P < 0.05 was regarded as significant for any of these comparisons.
RESULTS

Response to KCN i.p. in unsedated rats
In keeping with our preliminary data and data from the literature (12, 20) , we used a dose of KCN, which averaged 2.3 AE 0.3 mg (7 mg/kg) i.p. to produce a fatal outcome within 8 to 10 min in 75% of the animals presenting a coma. Indeed, at this dose, 8 out of 10 intoxicated rats presented a coma (loss of righting reflex and disappearance of all other reflexes) within 2 min (88 AE 29 s) following the injection. The two rats that did not display a coma following CN administration presented a transient phase of somnolence and apathy, and for one rat a profound muscular weakness but did not display an apnea or a gasping pattern. The phase of coma was typically preceded by a brief period of tachypnea. Breathing depression was observed very rapidly into the period of coma (129 AE 32 s after CN administration). The period of apnea was interrupted after 35 AE 16 s in every animal by a long period of gasping for another 165 AE 37 s until the animal died or spontaneously recovered. The longest period of gasping was 15 min. This phase consisted in the production of large breathes at a very slow frequency (approximately 30 breath/min) and with a brief inspiratory time mimicking the production of a hiccup ( Fig. 1) . These large breaths were associated with a loud and brief inspiratory grunting. Out of the eight rats that presented a coma and gasping, three survived. In these animals, the phase of gasping was progressively replaced by eupneic breathing, starting with the disappearance of the inspiratory grunting, followed by an increase in breathing frequency, and then a recovery of normal respiratory pattern. These three rats progressively recovered over a few hours, but remained somnolent. The remaining five animals presented a total disappearance in cardiac pulsations 555 AE 75 s after CN injection; the duration of the period of gasping in these animals was twice as long as in the overall group, and cardiac arrest occurred although the animals were still gasping.
Two animals that survived the phase of coma after presenting an apnea displayed severe motor deficits: one rat had a right hemiplegia that required its euthanasia within the first 12 h, whereas the second rat was euthanized after 48 h, as it was unable to eat and drink on its own. The histological examination of its brain (Figs. 2 and 3 ) revealed: diffuse bilateral and symmetric neuronal necrosis of the cortex affecting the superficial (outer) half of the frontoparietal (motor agranular) and infralimbic cerebral cortex. Necrosis spared the deepest 1/3 of the cortical grey. Necrosis of approximately 20% of neurons of the caudate putamen. Necrotic neurons were often surrounded by morphologically normal ones and were more frequent in the central portion. Bilateral and nearly diffuse neuronal necrosis of the mediodorsal nucleus of the thalamus, and bilateral neuronal necrosis and edema of the reticular substantia nigra, with minimal involvement of the compact substantia nigra. Bilateral and symmetric neuronal necrosis and edema of the hippocampal CA1 neurons immediately adjacent to the subiculum. The remainder of the hippocampus (CA1-3 and dentate gyrus) was unaffected, whereas the basolateral nucleus of the amygdala presented bilaterally symmetric neuronal necrosis; multifocal to coalescing necrosis and neuropil edema in approximately 60% of the Purkinje cells in the cerebellum. There were no visible lesions of the medulla.
FIG. 2.
Examples of lesions found in rats that spontaneously autoresuscitated. Discrete, bilateral, wedge-shaped regions of cortical necrosis were observed in the dorsal frontal cortex and the ventral parietal cortex adjacent to the piriform lobe. Necrotic foci were found approximately at the level of the rhinal fissure extending from cortical layers into the middle grey and endopiriform neucleus, but sparing the remaining piriform cortex and amygdala (outlined wedge regions shown in panels to the right). In the cortical regions between the focal lesions, moderate necrosis was observed as both individual neurons and discrete, roughly circular geographic foci. Furthermore, nearly diffuse, severe, and acute bilaterally symmetric neuronal necrosis affects the superficial layers of the frontoparietal (motor agranular) and infralimbic cerebral cortex (not shown, additional description in results). The deeper cortex displays marked neuropil edema, with sparing of the deepest third of the cortical grey. In addition, mild, acute neuronal necrosis is observed bilaterally and symmetrically in the medial anterior olfactory nucleus, whereas the piriform cortex was not affected (not shown). 
Outcome of CN-induced apnea in anesthetized animals
To dissect the mechanisms leading to autoresuscitation or to death, we first determined the lowest levels of KCN infusion, which led within 8 to 10 min to a central apnea. We found that this level corresponded to 0.15 mg/min (0.375 mg/kg/min). A total of 12 rats were studied using this rate of infusion. In all rats, an apnea occurred within 551 AE 120 s, as illustrated in Figure 4 . The total amount of CN required to stop breathing with this protocol averaged of 1.5 AE 0.4 mg (3.4 AE 0.7 mg/kg). Of note, CN infusion initially stimulated breathing within the first 2 to 3 min, reaching its maximum 242 AE 157 s into KCN infusion;VE increased from 299 AE 53 mL/min to 565 AE 83 mL/ min (P < 0.01). Following this initial stimulation, breathing frequency andVE started to decrease during the subsequent 3 min, whereas V T kept increasing until the animals presented few large breaths and then became apneic (Fig. 4) . Oxygen consumption significantly decreased by half throughout the period of CN exposure (P < 0.05; Fig. 5 ). Of note is that typical augmented breaths (sighs) were continuously produced during CN infusion, a likely marker of the stimulatin of the arterial chemoreceptors.
In contrast to breathing, mean arterial blood pressure (MABP) that displayed an initial drop, from 75 AE 14 mmHg to 55AE 10 mmHg, reaching its nadir at 200 s ( Fig. 5 ; P < 0.01) returned to baseline and remained approximately 86 AE 9 mmHg (P < 0.01 vs. baseline; Fig. 5 ) at the time of apnea. HR decreased from 355 AE 43 bpm to 285 AE 51 bpm at the moment of apnea ( Fig. 2 ; P < 0.05). Finally, left ventricular dP/dt max was lower than baseline (4,978 AE 849 mmHg/s vs. 3,752 AE 796 mmHg/s, P < 0.01), just before breathing stopped, as illustrated in Figure 5 .
CN infusion was interrupted as soon as breathing stopped. Out of these 12 animals, 10 presented a similar evolution following apnea (Figs. 4 and 6 ): blood pressure remained constant for approximately 1 to 2 min before decreasing very rapidly. The drop in MABP was linearly related to the decrease in cardiac contractility (dP/dt max) during this phase of apnea (Fig. 7) . In 6 out of these 10 animals, no intervention was applied and all the animals died by PEA, which occurred with a median of 208 s after the onset of apnea. Of note, PaO 2 reached 14 AE 4 mmHg 100 s into apnea. In the four remaining animals, mechanical ventilation was initiated as MABP dropped to 76 AE 21 mmHg (by the end of the second minute of apnea): ABP and cardiac contractility returned to, or even increased above, baseline as shown in Figures 4 and 6 . In these four animals, spontaneous breaths identified from the airway pressure signal resumed within 90 s, whereas the animal was still ventilated. In other words, mechanical ventilation counteracted the reduction in blood pressure, prevented PEA, and restored eupneic breathing. The same protocol was repeated in two of these animals 30 min after recovery and led to the exact same outcome. Figure 6 includes the responses obtained during these six trials.
The two remaining animals (out of initial 12) survived with no intervention; they displayed a gasping pattern of breathing 42 and 66 s into the period of apnea (Fig. 8) . The gasps consisted in few large breaths and resulted in autoresuscitation, as eupneic breathing spontaneously resumed in both animals and PEA did not occur. As a result, spontaneous survival, i.e., without any intervention, occurs in 17% of intoxications, only when gasps were present, whereas 100% of the animals recovered using mechanical ventilation. The circulatory effects of injection of 0.3 mg/min (twice the level leading to an ''isolated'' apnea) were studied, whereas the animals were mechanically ventilated in 10 animals. Figure 9 illustrates the hemodynamic effects of the exposure, whereas the averaged values are shown in Figures 10 and 11 . Baseline MABP and HR were 71 AE 13 mmHg and 434 AE 40 bpm, respectively. In major contrast to the low rate of 0.15 mg/ min, infusion of KCN at 0.3 mg/min produced a rapid and large drop in HR by approximately 100 bpm (reaching 347 AE 47 bpm, 110 s into infusion, as illustrated in Fig. 10 ), and then both MABP and HR kept decreasing reaching 46 AE 13 mmHg and 137 AE 17 bpm, 4 min into exposure. The reduction in blood pressure was mainly the result of a drop in cardiac output (CO), which decreased from 149 AE 33 mL/kg/min at baseline to 99 AE 38 mL/kg/min (P < 0.05) 210 s into infusion. CO kept decreasing until cardiac asystole occurred. In keeping with the drop of CO, femoral blood flow also decreased from 6.2 AE 2.0 mL/kg/min at baseline to 2.2 AE 1.2 mL/kg/min, 6 min into CN infusion (Fig. 10) . The drop in CO was related to a decrease in cardiac contractility, as LVSP and left ventricular dP/dt max decreased throughout KCN infusion (Fig. 10) . PEA was observed in all rats at 457 AE 34 s (median 455 s), i.e., at a similar time than needed to produce an PEA at the lower dose. The rats received 2.5 AE 0.4 mg (5.6 AE 0.6 mg/ kg) of CN to produce PEA. Until the last minute of shock, PaO 2 remained higher than baseline reflecting the reduction in pulmonary blood flow in keeping with the level of ventilation that was maintained by the ventilator as shown in Figure 12 .
Role of K in the effects of KCN infusion
Infusion of KCl was performed in five animals at a rate corresponding to that of KCN during the high-dose protocol. KCl infusion had no effect on the concentration of potassium in the blood (from 3.5 AE 0.4 meq/L to 3.8 AE 0.2 meq/L, NS) and was unable to reproduce any of the effects of KCN on circulation or breathing (Fig. 13) .
In addition, as shown in Figure 13 , in contrast to the effects of KCl infusion, KCN infusion changed the level of potassium from 3.6 AE 0.3 meq/L to 4.5 AE 0.2 meq/L (P < 0.05). This increase in potassium remained, however, trivial (0.9 meq/L) and was associated with a severe base deficit which decreased from À3.3 AE 1.0 meq/L to À20.3 AE 3.3 meq/L, whereas lactate concentration increased from 3.3 AE 0.9 meq/L to 5.8 AE 0.7 meq/ L. In other words, we did not find any evidence that the potassium contained in KCN contributed to any of the effects   FIG. 4 . Effects of continuous infusion of KCN (0.375 mg/kg/min) on breathing (inspiratory flow) and ABP in one rat. Breathing was stimulated by the infusion of KCN before stopping after 8 min. In panel A, ABP was sustained during the phase of infusion and the initial 2 min of apnea before dropping leading to cardiac arrest despite the cessation of the KCN infusion. The inset on the top-right corner shows the ECG signal during the period of asystole, reflecting the presence of a PEA. Note that no gasping was produced during the phase of apnea in this rat. Panel B shows effects of CN as in panel A, but mechanical ventilation was initiated 90 s into the period of apnea, whereas blood pressure had already dropped by half. Note the restoration of hemodynamics followed by the recovery of a spontaneous eupneic breathing activity resulting from the mechanical ventilatory support that was maintained for 30 s only (gray area). ABP indicates arterial blood pressure; ECG, electrocardiogram; KCN, potassium cyanide; PEA, pulseless electrical activity.
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of CN infusion nor did it produce measurable effects on respiration of circulation.
DISCUSSION
The mechanisms leading to death versus autoresuscitation (survival) during acute CN intoxication seem to differ according to the level of exposure. This difference has important clinical implications when considering and designing appropriate therapies for acute life-threatening CN intoxication. Although we found that the direct cause of death during CN infusion was typically a PEA, the mechanisms leading to PEA clearly depend on the level of exposure. Indeed, as developed in the following paragraphs, the deterioration in cardiac function (reduction in CO and contractility) could result from a primary apnea, at a lowest lethal range of CN exposure. The production of gasps can, in this situation, lead to spontaneous recovery, but death can also be prevented by mechanical ventilation. At higher levels of intoxication, a primary and rapidly developing cardiac depression led to a cardiac arrest by PEA even if mechanical ventilation was initiated and PaO 2 maintained constant.
Noninhaled forms of CN intoxication
The debate over the models to be used to study CN intoxication is not new and any reader interested in the question of CN poisoning could be rapidly lost amid the studies using inhaled, i.p., oral, or i.v. administration of CN-not to mention the almost infinite combinations of protocols that can be offered, from short, repetitive, or prolonged exposures at low or high levels. Of note, the systemic administration of a solution of CN has been widely used because it is a convenient and safe way to study CN poisoning, even though i.v. or i.p. administration of KCN or NaCN do not correspond to a clinically relevant scenario of intoxication. Yet, these systemic administrations of a CN salt can provide precious and clinically relevant information. In other words, a physiological study does not have to be totally faithful to real-life modalities of exposure to be relevant, if one wants, for instance, to dissect or understand the natural history of breathing and circulatory depression.
The experimental approaches we used produced effects that are extremely close to those produced by an acute CN intoxication by ingestion (10, 11) . These forms of poisoning are regarded as a potential source of intoxication during a criminal act or a potential terrorist attack. Recent studies in rodents FIG. 5 . Cardiovascular and ventilatory parameters in baseline conditions and during the last 30 s preceding the apnea while infusing KCN at 0.375 mg/kg/min in 12 rats. Data AE SD values are shown. Note that MABP was unchanged at the moment of apnea, whereas HR and dP/dt max were moderately decreased. * Significant difference between groups, P < 0.05. HR indicates heart rate; KCN, potassium cyanide; MABP, mean arterial blood pressure.
(10, 11) have established how rapidly lethal can oral intoxication be (within minutes). These effects are very well mimicked by an i.p. injection because during both oral and i.p. administration the diffusion of CN into the blood does not depend on the level of breathing and CN will continue to diffuse at the same rate regardless of the levels ofVE. The lack of effects of potassium in KCN was also important to clarify in our model, and we found that potassium did not contribute at all to the response to KCN.
Circulatory failure during CN intoxication-At a rate of 0.15 mg/min i.v., CN provoked a central terminal apnea within 7 to 8 min followed by a depression in circulation leading to PEA in all animals except if gasping was produced. At this level of exposure, central apnea was consistently observed at a time when blood pressure was still maintained around or even above baseline levels. In most cases, breathing remained The time of apnea was considered as time zero (dashed line). In four rats (six tests, closed circles), ventilatory support was initiated 90 s into the period of apnea, whereas six rats (six tests, open circles) were not ventilated. Hemodynamics (MABP, LVSP, and dP/dt max) were maintained for approximately 60 s, after the onset of apnea, and then MABP, LVSP, and dP/dt max started to decrease, until PEA occurred in the nontreated group. The circulatory parameters and cardiac function were restored by the mechanical ventilation, preventing PEA in all the treated rats. The shaded area shows the duration of ventilatory support (approximately 30 s). * Significant difference between groups, P < 0.05. HR indicates heart rate; KCN, potassium cyanide; LVSP, left ventricular systolic pressure; MABP, mean arterial blood pressure; PEA, pulseless electrical activity.
FIG. 7.
Average MABP as a function of dP/dt max throughout the phase of apnea (after the cessation of KCN infusion) in the group of six rats that did not autoresuscitate. The drop of MABP clearly paralleled the decrease in cardiac contractility during the period of apnea. KCN indicates potassium cyanide; MABP, mean arterial blood pressure.
FIG. 8.
Effects of continuous infusion of KCN (0.375 mg/kg/min) on breathing and ABP in one rat, same protocol and legends as in Figure 1 . In contrast to the test displayed in Figure 4 , gasping was produced during the phase of apnea ( * ). This pattern was observed in two rats allowing spontaneous breathing to resume and blood pressure to rise (autoresuscitation). ABP indicates arterial blood pressure; KCN, potassium cyanide.
inhibited until death, whereas blood pressure and cardiac contractility decreased rapidly leading to cardiac arrest (see Figs. 4 and 7) when PaO 2 reached values below 15 mmHg. Of note, this value of 15 mmHg corresponded to a level of hypoxemia which we previously found to be able to stop ventilation per se (26) , preventing therefore breathing to spontaneously recover during CN intoxication. Each time mechanical ventilation was initiated, when the blood pressure FIG. 9 . Recording in one mechanically ventilated rat displaying the ECG signal, arterial pressure, ventricular pressure, dP/dt max and computed cardiac output at various times during KCN infusion at a higher dose (0.75 mg/kg/min). In this example, CO started to decrease between 3 and 4 min into KCN infusion along with an abrupt drop in HR and dP/dt max, rapidly leading to a severe cardiogenic shock and a pulseless electrical activity, as demonstrated by the persistence of an ECG signal without effective cardiac contractions. CO indicates cardiac output; ECG, electrocardiogram; HR, heart rate; KCN, potassium cyanide.
FIG. 10.
Average AE SD MAP, HR, LVSP, and dP/dt max in the 10 rats exposed to 0.75 mg/kg/min KCN. Data have been compared with the effects of an infusion of KCl (equimolar infusion, 11.5 micromol/kg/min). In marked contrast to KCl infusion, all cardiac parameters significantly decreased within 330 s into KCN infusion leading to PEA within 7 to 8 min. Note that the first rats died by PEA (LVSP < 10 mmHg) at 400 s. * Significantly different from baseline, P < 0.05. HR indicates heart rate, KCl, potassium chloride; KCN, potassium cyanide; MAP, mean arterial pressure; PEA, pulseless electrical activity; LVSP, left ventricular systolic pressure.
was already decreased but still maintained above 30 to 40 mmHg, cardiac contractility and circulation could be restored and eupneic breathing resumed, although no antidote was administered. The same effect was observed when gasping was produced-a rare event in our anesthetized model-in contrast to the effects of CN in unsedated animals, wherein gasping and autoresuscitation was much more frequent (Fig. 1) . Resuscitation, following CN intoxication, seems therefore to depend on the partial restoration in alveolar ventilation (whether produced by gasps or mechanical ventilation) (27) via an increase in PaO 2 (26) and possibly the beneficial effects of mechanical ventilation or gasping on cerebral blood flow (26, (28) (29) (30) . This observation also suggests that the effects of CN on the brainstem respiratory neurons can be rapidly reversed.
For higher levels of intoxication, blood pressure and cardiac contractility are affected despite constant ventilatory support. In these conditions, the depressive effect of CN on cardiac contractility was the primary mechanism leading to death, which also develops within 7 to 8 min.
The determination of the precise mechanisms leading to central apnea and cardiogenic shock is beyond the scope of this study. It has been shown that the effect of blocking the mitochondrial complex i.v. by CN is an immediate impediment of ATP formation (31) , which closely mimics the effects of acute anoxia produced, for instance, by breathing pure nitrogen or during cardiac arrest-induced brain stem ischemia (26, 27) . During acute anoxia, the production of gasps following the inhibition of the central pattern generator (32) has long been described (33, 34) , and the sequence of events leading to autoresuscitation mimics the effects of CN poisoning we are reporting in the unsedated rat model. The depression in cardiac contractility is obviously potentiated by the effects of apneainduced hypoxemia which comprises the direct effects on cardiac contractions of the reduction in ATP, local acidosis (4, 7) and possibly non-ATP-related effects on calcium transients (35) .
It should be pointed out that the production of gasps, which seems to be extremely favorable during ingestion or systemic administration of CN, would certainly become deleterious during CN inhalation if exposure to CN persists. Gasps are large and deep breaths that allow the transport of CN to the alveolar regions and its diffusion to the pulmonary circulation to resume, resulting in cyclic periods of autoresuscitation and apnea until a final cardiac arrest occurs. A similar reasoning can be applied following CN ingestion about the amount of CN that might be inhaled in the form of HCN released from the stomach into the upper-airways.
Clinical implications of these observations for the treatment of CN poisoning-If the lethality and morbidity of CN poisoning result from a primary depression in breathing, cardiac FIG. 11 . Mean AE SD values of CO, FBF, andVO 2 in the 10 rats exposed to 0.75 mg/kg/min KCN. Data have been compared with the effects of an infusion of KCl (equimolar infusion, 11.5 micromol/kg/min). Same legend as in Figure 10 . Again, note the very rapid decrease in cardiac output and VO 2 despite mechanical ventilation unrelated to the effects of potassium per se. CO indicates cardiac output, FBF, femoral blood flow; KCl, potassium chloride; KCN, potassium cyanide;VO 2 , oxygen consumption.
FIG. 12.
PaO 2 (mean AE SD) versus dP/dt max and FBF (mean AE SD) before and after intravenous administration of KCN at two different levels. At the low level of intoxication (0.375 mg/kg/min), data were obtained at baseline and 2 min after the apnea in the three animals that were not mechanically ventilated and did not present any spontaneous gasping. These data were compared with the effects of CN infusion at 0.75 mg/kg/min (n ¼ 4). In these animals, arterial blood gases were collected when dP/dtmax reached a level similar to that obtained 2 min into the apneic period following the low dose KCN infusion. PaO 2 was drastically different between these conditions ( # P < 0.05) despite similar degree of cardiac depression; at the highest levels of CN infusion, the depression of cardiac function occurred in mechanically ventilated animals without any change in PaO 2 level. Also note the severity of hypoxemia, which led to PEA in the group receiving 0.375 mg/kg/min. FBF indicates femoral blood flow; KCN, potassium cyanide; PEA, pulseless electrical activity.
contractility or a combination of both, a given antidote may have a different outcome in keeping with the kinetics of its impact on CN metabolism and on the activity of medullary neurons or cardiomyocytes. Conversely, in conditions wherein the anoxic/ischemic or postischemic injuries secondary to an acute respiratory failure are dictating the short-and long-term neurological outcome-rather than the effects of CN per sethe acute circulatory failure as well as neurological deficits might not be efficiently counteracted by CN antidotes, which delay of action may be within minutes. Our present study suggests that the level of oxygenation of the cardiac cells and of the medulla contributes to the fatal outcome of CN poisoning at least in the less ''severe'' lethal forms. Any antidote administered during this period must take into account whether gasps can be produced, as the improvement of circulation will likely improve the diffusion of drugs if non-i.v. routes are to be used.
As a consequence, the lack of efficacy of any non-i.v. antidote in an animal model, in which gasping is blunted, should be challenged and retested using awake animal models. Perhaps more importantly, as the level of oxygenation becomes critical for the cardiac function and the rapid correction of hypoxia/anoxia becomes necessary, administration of antidotes without initiating mechanical ventilation may incorrectly lead to the rejection of candidate antidotes potentially very effective on cardiac contractility.
Finally, immediate recovery is not the only predictor of efficacy of an antidote, as dreadful neurological necrosis develops even after spontaneous autoresuscitation from CN poisoning (Figs. 2 and 3) . This illustrates that autoresuscitation should not always be the defining marker of a benign form of intoxication or success of an antidote.
In conclusion, the mechanisms leading to cardiac arrest during CN intoxication are primarily related to a reduction in cardiac contractility resulting in PEA; apnea-induced hypoxia can create a vicious circle maintaining the depression in respiratory medullary neurons produced by CN leading to a depression in cardiac contractility; implementing mechanical ventilation when apnea is present, although circulatory failure is predominantly the consequence of apnea-induced hypoxemia, has striking effects on circulation and can allow eupneic breathing to resume. This effect is, however, present only in a narrow range of CN exposure and as long as circulation is maintained; whenever blood pressure is rapidly affected, a cardiac asystole develops due to a primary depression in cardiac contractility by CN; when developing new antidotes against CN, long-term effects are essential to evaluate, as severe neuronal necrosis can develop even in animals presenting autoresuscitation; and finally, the present results suggest that CN intoxication by noninhalation exposure represents a form of CN poisoning wherein gasp-induced autoresuscitation is an important mechanism of survival. 
